Drug Discovery

actavis-new-drug-application-nda-for-progestin-only-transdermal-contraceptive-patch-norethindrone-transdermal-delivery-system-gets-fda-nod

Actavis 'pregnancy preventer' gets FDA nod

  • US
  • |
  • News

Singapore: US FDA has accepted Actavis' New Drug Application (NDA) for a progestin-only transdermal contraceptive patch (Norethindrone Transdermal Delivery System) for use by women to prevent pregnancy. The acceptance of the NDA for... Read more

gilead-leukemia-study-gets-complete-repsonse

Gilead leukemia study gets complete response


  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Gilead Sciences' phase II study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, targeted,... Read more

bioduro-opens-discovery-lab-in-shanghai

BioDuro opens discovery lab in Shanghai


  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: BioDuro, a PPD Company, has opened a new state-of-the-art laboratory in Shanghai, China, strengthening its ability... Read more

protagonist-ironwood-expand-peptide-drug-discovery-collaboration

Protagonist, Ironwood expand peptide R&D deal

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Protagonist Therapeutics and Australia-based Ironwood Pharmaceuticals expanded their research collaboration leveraging... Read more

astrazeneca-legochem-collaborate-to-develop-antibiotic-resistant-bacterial-infections-drug

AstraZeneca, LegoChem drug to curb superbugs

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AstraZeneca has formed collaboration with Korea's LegoChem Biosciences to develop a novel antibiotic to treat drug-resistant... Read more

national-health-and-medical-research-council-nhmrc-gives-usd200-000-to-professor-ian-frazer-to-develop-a-novel-dna-vaccine-for-hpv

Ian Frazer gets $200k to make HPV DNA vaccine

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Professor Ian Frazer and his team at the University of Queensland, have been awarded grant from Australia's National Health and... Read more

clinical-trial-patient-recruitment

Astellas completes patient recruitment in drug trial

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Japanese company Astellas Pharma has completed patient recruitment for the isavuconazole phase III registration study SECURE.... Read more

clinuvel-clinical-trial

Clinuvel gets positive results in Scenesse trial

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Australian company Clinuvel Pharmaceuticals reported successful, statistically significant results from its US phase IIa pilot... Read more

induced-pluripotent-stem-cell-assay

GE fortifies iPS cell-derived cellular assay avenue

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: GE Healthcare Life Sciences has licensed Cellular Dynamics International, US-based commercial producer of human induced pluripotent... Read more

research-collaboration-china

Astrazeneca, China university in research deal

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: AstraZeneca has signed a research collaboration with Fudan University, one of China's leading academic institutions in the area... Read more

can-india-become-a-global-drug-discovery-collboration-hot-spot

Global collaborations is the way forward for drug discovery

  • India
  • |
  • Analysis
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry services to big pharma... Read more

hope-for-alzheimer-s-and-parkinson-s-patients-university-college-london-ucl-and-eisai-form-research-alliance-therapeutic-innovation-group-tig

Eisai, UCL form neuro R&D alliance

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: University College London (UCL) and Japanese pharmaceutical company Eisai, have entered into a new agreement to establish a Therapeutic... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X